ClinicalTrialsFinder
RecruitingEarly Phase 1NCT05516472

Fecal Microbiota Transplantation in Kidney Stone Patients

Fecal Microbiota Transplantation (FMT CAPSULE DE, FMPCapDE, MTP-CP101) in Kidney Stone Patients (FMT IND STUDY)

Sponsor

Joshua Stern

Enrollment

36 participants

Start Date

Oct 10, 2024

Study Type

INTERVENTIONAL

Conditions

Kidney Stones

Summary

The purpose of this study is to measure the impact of Microbial Transplant Therapy (MTT) on 24-hour urine parameters in recurrent hypercalciuric and hyperoxaluric kidney stone formers.

Eligibility

Min Age: 18 YearsMax Age: 69 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Microbial Transplant Therapy and a drug called Placebo for people with kidney stones. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 69 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMicrobial Transplant Therapy

Participants will take microbial capsules, 2 capsules daily for 7 days

DRUGPlacebo

Participants will take placebo capsules

Locations(1)

Park City Hospital

Park City, Utah, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05516472

Related Trials

Ureteral Access Sheaths in Endoscopic Kidney Stone Surgery

NCT075689901 location

Endogenous Oxalate Synthesis in Idiopathic Calcium Oxalate Kidney Stone Disease

NCT069893202 locations

Evaluation of Eye Gaze Sharing in the Operating Room

NCT071733091 location

Trial of Ureteroscopy vs Steerable Continuous Flow Aspiration Technology

NCT071018093 locations

Oxalate-Driven Host Responses in Kidney Stone Disease

NCT054175681 location